Insights On Solid Dose Manufacturing
-
Precision In Miniature: Optimizing Multiparticulate Formulations For Pediatric Oncology
9/9/2026
When an oral liquid formulation of crizotinib failed pediatric trials due to intolerable taste and irritation, a multiparticulate approach offered a technically demanding but viable path forward.
-
Adapting To Evolving Needs: How Modular Cleanrooms Enhance Safety In Pharmaceutical Manufacturing
6/9/2026
High-potency therapies demand stringent containment and worker safety. Discover how scalable, modular infrastructure simplifies compliance and protects product integrity in regulated facilities.
-
Zhunan Facility Site VR Tour
12/23/2025
Bora’s 36,000-square-meter Zhunan, Taiwan facility delivers flexible, high-quality cGMP oral solid dose manufacturing with access to major markets including North America and the EU.
-
Almac Pharma Services Capabilities Update November 2026: Bioavailability And Solubility
11/18/2026
Optimize bioavailability with biorelevant solubility, dissolution, and in vitro permeability testing to guide bioenhancement strategies and formulation development.
-
Rational Design And Material-sparing Strategies For Enabled Intermediates And Drug Products
9/9/2026
A material-sparing strategy integrating formulation mapping, lab-scale spray drying, and compact screening can accelerate risk identification and inform first-round tablet formulation decisions for poorly soluble APIs.
-
Raise Your Standards With Downflow Booth Airflow Containment
1/30/2026
Ensure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.
-
Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing
6/30/2025
Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.
-
The Environmental Case For Single-Use Systems
11/3/2026
Plastic waste is easy to see, but the water, steam, and energy used to clean reusable equipment between batches may carry the larger burden. A life cycle comparison tests that.
-
Low-Bioburden Powders For Terminal Sterilisation
2/24/2026
Low‑bioburden powders for reconstitution demand strict microbial control, advanced formulation, and specialised manufacturing, making CDMO expertise vital for modern biopharma.
-
Predicting Softgel Stability And Shelf Life Using Accelerated Modeling
7/15/2026
Predict ibuprofen softgel shelf life in 21 days instead of years. ASAPprime modeling identified PEG-ester degradants as the limiting factor, estimating 5.5-year and 3.8-year shelf lives before long-term studies concluded.